Home Novartis

Novartis

acquired
Post-IPO Round
Drug Development and Manufacturing
Basic
Enterprise Profile
LinkedIn

Basic Information

Novartis is a pharmaceutical and biotechnology multinational company headquartered in Basel, Switzerland. Its core businesses include various patented drugs, consumer health, generics, eye care, and animal health. Novartis was founded in 1996 through the merger of two chemical and pharmaceutical companies based in Basel: Ciba-Geigy and Sandoz. Novartis researches, develops, manufactures, and markets a range of healthcare products worldwide. The company’s innovative medicines division provides patented prescription drugs to improve health outcomes for patients and healthcare providers. The Sandoz segment offers active pharmaceutical ingredients and finished dosage forms in areas such as cardiovascular, central nervous system, dermatology, gastrointestinal and hormone therapies, metabolism, oncology, ophthalmology, pain management, and re-treatment.
Novartis AG
Basel,CantonofBasel-City,Switzerland
more than 500 people
January 01, 1996
eric.althoff@novartis.com

Enterprise Profile

Industrial Sector
New Drug Development Manufacture of Chemical Pharmaceutical Preparations Manufacture of Biological Pharmaceutical Products Immune Cell Therapy Gene Therapy
Technology
Gene Technology Targeted Technology Immunological Techniques Cell Technology Stem Cell Technology Protein Technology
Concept
Cardiology Department Department of Rheumatology and Immunology Ophthalmology Dermatology Department # Brain Sciences Cardiovascular Disease Therapeutic Products Ovarian Cancer Lung Cancer Gastric Cancer Esophageal Cancer Lymphoma Colorectal Cancer Prostate Cancer Leukemia Lupus Erythematosus Depression
Application Scenarios
Generic Drug Chemical Drug Innovative Drugs Prescription Drug Monoclonal Antibody Over-the-Counter Drugs Cell and Gene Therapy Small Nucleic Acid Drugs AI+Pharmaceuticals

LinkedIn